How to avoid the next nitrosamine crisis: 5 lessons learned about impurity detection
11 Mar 2020
When a crisis occurs, hindsight is a great teacher. Any company creating products that impact human health can learn from the recent nitrosamine contamination of heart drugs by looking at their own quality processes for anything that could result in a similar contamination issue. Analytical data should have been able to support confidence in the quality of manufacturing and did in fact first identify the presence of nitrosamines, but not before the contamination had spread. In this webinar, we cover key analytical tests, how to improve methods and gain more information about your samples and how Waters analytical expertise can help your scientists and chemists support the quality of your products, be they food, cosmetics, or drugs.
Key Learning Objectives:
- Key analytical tests that might be overlooked
- Enhancing analytical tests to get more information about your samples
- Improving analytical methods in regulated environments
- Leveraging automation to minimize manual intervention and detailed review requirements
- Using scientific review to look for quality risks rather than data errors
Who should attend?
- Lab managers
- Lab directors
- Quality teams
- Quality leaders
All webinar participants can download a certificate of attendance, and a learning outcomes summary document for continuing education purposes.